Compound 1000
Identifiers
- Canonical SMILES:
OC(=O)C1CCN(CC1)c1ccccc1Sc1ccc(cc1C(F)(F)F)[C@@H]1C[C@H]1C(=O)NCCCN1CCCC1=O
- IUPAC name:
1-[2-[4-[2-[3-(2-oxopyrrolidin-1-yl)propylcarbamoyl]cyclopropyl]-2-(trifluoromethyl)phenyl]sulfanylphenyl]piperidine-4-carboxylic acid
- InChi:
InChI=1S/C30H34F3N3O4S/c31-30(32,33)23-17-20(21-18-22(21)28(38)34-12-4-14-36-13-3-7-27(36)37)8-9-25(23)41-26-6-2-1-5-24(26)35-15-10-19(11-16-35)29(39)40/h1-2,5-6,8-9,17,19,21-22H,3-4,7,10-16,18H2,(H,34,38)(H,39,40)/t21-,22+/m0/s1
- InChiKey:
BDMKWKGKWYADLX-FCHUYYIVSA-N
External links
168318116 |
23241104 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
0 | 1 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
LFA / ICAM | 6.21 | immune system disease | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 589.22 g/mol | |||
HBA | 7 | |||
HBD | 2 | |||
HBA + HBD | 9 | |||
AlogP | 3.56 | |||
TPSA | 89.95 | |||
RB | 11 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 0 | 1 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5548 | Periciazine | DB01608 | |
0.5490 | Butaperazine | DB13213 | |
0.5274 | Propiopromazine | DB11540 | |
0.5223 | Carphenazine | DB01038 | |
0.5188 | Mequitazine | DB01071 | |
0.5072 | Etymemazine | DB11517 | |
0.5036 | Triflupromazine | DB00508 | |
0.5000 | Metopimazine | DB13591 | |
0.5000 | Fluphenazine | DB00623 | |
0.5000 | Trifluoperazine | DB00831 | |
0.4966 | Acepromazine | DB01614 | |
0.4936 | Acetophenazine | DB01063 | |
0.4868 | Propiomazine | DB00777 | |
0.4792 | Thioridazine | DB00679 | |
0.4776 | Methdilazine | DB00902 |